# Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology > **NIH NIH T32** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2022 · $205,642 ## Abstract Abstract. There has been a substantial growth in nanotechnology research in cancer demonstrating that nanotechnology could provide unique and otherwise unattainable solutions to cancer management including very early cancer detection, accurate molecular specific diagnosis and treatment that diminishes side effects. However, achieving this promise is extremely challenging because it requires overcoming multiple constraints imposed by translational barriers in clinical applications of nanomaterials that is multiplied by complexity of cancer biology. Currently, there is a growing gap between new discoveries coming at a fast pace from academic labs and their translation into clinic. Therefore, there is an urgent need in addressing this gap in cancer nanotechnology translational pipeline. To this end, we have designed a novel training program to educate future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, who are keenly aware of the needs and demands of clinical environment as well as of major challenges of translational research. We believe that the only way to train cancer translation minded Ph.D. researchers is to insert them into the environment of an outstanding cancer center. Therefore, our program is based on a close collaboration between The University of Texas MD Anderson Cancer Center and Rice University. As part of our program, we have developed a comprehensive plan for recruiting trainees from diversity groups that are historically underrepresented in health-related research, including women, individuals from racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. Our training program includes multidisciplinary mentorship of translational research projects combined with multidisciplinary, hands-on coursework and seminar experiences. All trainees will work with at least two program faculty mentors (one from Rice and one from MD Anderson) to define and carry out an independent research problem. Didactic coursework will prepare them to contribute to research projects that directly address barriers to translation of nanotechnology-based approaches and to develop the skills needed to define and lead such projects. Incoming trainees will participate in a unique one-week-long boot camp in “Cancer Management and Nanotechnology” that provides an overview of current opportunities and barriers in the field. Trainees will develop foundational background in the field from program specific seminar series and by taking courses related to translational cancer or nanotechnology topics. Trainees will gain essential writing skills through scientific writing seminars and by writing a NIH grant proposal that will be reviewed by a NIH-style Mock Study Section. Finally, trainees will gain important lab management skills by participating in a short hands-on course providing an introduction to laboratory and project management. At the end of the program, fellow... ## Key facts - **NIH application ID:** 10410744 - **Project number:** 2T32CA196561-06 - **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR - **Principal Investigator:** Gang Bao - **Activity code:** T32 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2022 - **Award amount:** $205,642 - **Award type:** 2 - **Project period:** 2015-09-01 → 2027-03-31 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/10410744 ## Citation > US National Institutes of Health, RePORTER application 10410744, Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology (2T32CA196561-06). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10410744. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*